ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

January 24, 2003

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

Northwestern’s Warren Kibbe Named Director of NCI CBIIT

June 26, 2013

Obese Men More Likely To Have Aggressive Tumors

February 27, 2004

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013